Field Orthopaedics

What Field Orthopaedics does

Field Orthopaedics Pty Ltd is a Brisbane, Australia-based medical device company founded in 2015 that designs, develops and commercialises orthopaedic implants purpose-built for hand and upper-extremity surgery. Its portfolio comprises four products: the NX Nail System (described as the most comprehensive intramedullary nailing system on the market for hands, treating extra-articular neck and shaft fractures via a minimally invasive procedure); the Sterile NX Nail System (a single-use sterile variant cleared by FDA in February 2023); the Micro Screw System (a fully cannulated titanium-alloy compression screw in 1.5mm and 2.0mm diameters, claimed to be the world's smallest cannulated screw for small-bone hand and wrist fractures); and the Griplasty System / EASS (an all-suture suspensionplasty with a 'V-Sling' design for thumb carpometacarpal joint osteoarthritis, FDA cleared September 2024 and TGA ARTG included May 2025). Development economics cited by the company are 65x cheaper and 2.5x faster than the average US medical device, reflecting a small, agile R&D model anchored by a co-founder who is a practicing hand surgeon (Prof Greg Couzens, CMO).

The company operates a hardware-sales revenue model through two-tier exclusive distribution. Since September 2022, Medartis AG (Basel, Switzerland; MED.SW) holds exclusive global distribution rights for the NX Nail and Micro Screw lines, integrating them into Medartis' APTUS hand portfolio across 50+ countries. Since May 2025, Spartan Medical, a US Service-Disabled Veteran-Owned Small Business, distributes the Griplasty System exclusively into VA Medical Centers and DoD facilities through its 700+ federal contracts, while Field Orthopaedics retains its own distribution network for non-US Griplasty markets including Australia. End customers are orthopaedic and hand surgeons, hospitals, ambulatory surgery centres, and federal healthcare facilities. Sales motions combine surgeon case-report programs, peer-reviewed clinical evidence, and presence at AAOS and ASSH annual meetings (with cadaveric labs such as the October 10, 2025 ASSH Griplasty Lab in Vancouver).

The company has raised AUD $20.8 million in Series A financing in August 2024 ($12M new capital plus $8.8M debt-to-equity conversion), led by Tynan Family (US) and Acorn Capital (Australia), with participation from Flannery/Ilwella (Australia). The board is chaired by Quentin Flannery and includes Mark Foster (former Smith+Nephew US VP, current Trice Medical CEO). CEO Patryk Kania joined in 2021 with senior experience across Smith+Nephew, Arthrocare, Abbott Vascular, J&J and Roche. Operating geographies span Australia, the United States, New Zealand, South Africa, and Switzerland (via Medartis). Customer-validated clinical evidence includes more than 250 Griplasty cases in a US limited market release and named surgeon case reports from institutions including Orthopedic ONE, OrthoCarolina, Orlando Health, University Hospitals Cleveland Medical Centre and Lexington Clinic.

Name

Field Orthopaedics

Legal name

Field Orthopaedics Pty Ltd

Website

https://fieldorthopaedics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Field Orthopaedics is a Brisbane-based medical device company that develops and commercialises orthopaedic implants purpose-built for hand and upper-extremity surgery, including intramedullary nails, the world's smallest cannulated compression screws, and an all-suture CMC suspensionplasty, sold globally through exclusive partnerships with Medartis AG and Spartan Medical.

Ownership category

akta.pro rank

Headquarters

HQ city

Brisbane

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Implant Sales: Field Orthopaedics generates revenue through the sale of its proprietary medical implants (NX Nail System, Micro Screw System, Griplasty System) primarily through exclusive distribution partnerships. Products are sold to healthcare providers including hospitals, ambulatory surgery centers, and orthopaedic surgeons.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Field Orthopaedics designs, develops, and commercializes proprietary orthopaedic implants exclusively for hand and upper-extremity surgery. Its portfolio comprises the NX Nail System (intramedullary nailing for hand fractures), the Sterile NX Nail (single-use sterile variant), the Micro Screw System (the world's smallest cannulated compression screw, 1.5mm/2.0mm), and the Griplasty System (an all-suture suspensionplasty device for thumb CMC joint osteoarthritis). Devices are sold through exclusive distribution partnerships (Medartis AG globally for NX Nail/Micro Screw; Spartan Medical for Griplasty in U.S. federal channels) to hospitals, ambulatory surgery centers, and orthopaedic/hand surgeons.

Product overview

Field Orthopaedics is a medical device company with four commercially available products for hand surgery. The portfolio includes: (1) the Griplasty System for thumb CMC arthritis management using an all-suture suspensionplasty approach, (2) the NX Nail System for intramedullary fracture fixation of metacarpal and phalangeal bones, (3) the Sterile NX Nail as a single-use sterile version of the NX Nail, and (4) the Micro Screw System as the world's smallest cannulated compression screw for small bone fractures. The NX Nail and Micro Screw are distributed globally by Medartis AG under an exclusive agreement, while the Griplasty System is distributed through Field Orthopaedics' own network. The company also offers case report programs and surgical technique documentation supporting clinical practice across its product range.

Differentiator

Problem solved

Functional benefit

Products and services

• Griplasty System (Extremity All Suture System / EASS) A suspensionplasty device for surgical management of thumb carpometacarpal (CMC) joint osteoarthritis. Features single-incision deployment with V-Sling implant design providing multi-axis support through bi-cortical anchor deployment, compatible with trapeziectomy and tendon transfer procedures. For orthopaedic and hand surgeons.
• NX Nail System The most comprehensive intramedullary nailing system on the market for hands, designed to treat extra-articular neck and shaft fractures by providing rigid fixation, stability, and an environment for bone healing through a minimally invasive procedure for accelerated return to function and mobility. For orthopaedic and hand surgeons.
• Sterile NX Nail System Single-use sterile version of the NX Nail implants, designed to save time and cost in sterilisation and surgical preparation processes, providing a smart, cost-effective approach to fracture fixation for surgical teams, hospitals and healthcare clinics. Available in the U.S. via Medartis Inc.
• Micro Screw System The world's smallest cannulated compression screw system for managing small fractures in the hand and wrist. Fully cannulated design with 1.5mm and 2.0mm diameter options, ranging from 6mm-22mm in length. Features reinforced head geometry for strength during insertion and compression, optimised lagging geometry, and single-shot insertion over K-wires. Manufactured from Titanium alloy (Ti-6Al-4V ELI). For orthopaedic and hand surgeons.

Quantifiable outcome

• Over 250 patients successfully managed with Griplasty in U.S. limited market release
• +3 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Spartan Medical, Inc.coreChannel Partner/ Reseller/ Distributor · 16 May 2025U.S. distribution agreement for Griplasty System. Spartan Medical is a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Rockville, Maryland, with 17-year track record and 700+ federal contracts. Provides access to hundreds of VA Medical Centers and DoD facilities nationwide. Recognised as 'top priority vendor' for Veterans Health Administration.
• Medartis AGcoreChannel Partner/ Reseller/ Distributor · 29 September 2022Exclusive global distribution partnership for NX Nail and Micro Screw systems. Field Orthopaedics' products added to Medartis' comprehensive hand portfolio, extending global distribution footprint. Distribution commenced Q4 2022. Medartis is headquartered in Basel, Switzerland (MED.SW) and employs 700+ individuals across 14 locations in 50+ countries.
• Dr. Marc Richard (Duke University)minorOthersAssociate Professor of Orthopaedic Surgery at Duke University who provided expert commentary on Griplasty System: 'The Griplasty implant optimizes the suspension of the thumb to maintain length and support anatomical planes of movement.' Key opinion leader supporting product launch.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Stryker Corporation: Stryker is a global orthopaedic medical device incumbent with a broad hand and upper-extremity portfolio including plates, screws, and intramedullary nails. While Stryker's hand franchise is part of a much larger orthopaedic business (and it competes head-on in trauma/extremity fixation), it is the type of large incumbent Field Orthopaedics must outcompete or partner with for surgeon mind-share.
• Zimmer Biomet: Zimmer Biomet is a global orthopaedic and extremities leader with a dedicated hand and wrist portfolio as part of its broader extremities and trauma business. The company competes with Field Orthopaedics across trauma and small-fragment fixation indications and operates at a vastly larger scale across multiple geographies.
• Integra LifeSciences: Integra LifeSciences operates a hand and upper-extremity franchise (including the Integra® and Small Bone Innovations product lines) covering plates, screws, and external fixation. The company competes with Field Orthopaedics in small-bone and hand fracture management and is a publicly traded diversified medtech player.
• Johnson & Johnson (DePuy Synthes): DePuy Synthes (J&J MedTech) operates the largest orthopaedic trauma and extremities franchise globally, with comprehensive plate, screw, and intramedullary nail systems. It is the dominant incumbent in hand and upper-extremity fixation and the standard against which Field's hand-focused innovation is benchmarked by surgeons.
• Smith+Nephew: Smith+Nephew is a global medical device major with a meaningful sports medicine, extremities, and trauma fixation portfolio — historically a training ground for several Field Orthopaedics senior leaders (including CEO Patryk Kania). S+N competes with Field in upper-extremity trauma and reconstruction indications and represents both a competitor and a potential future acquirer of Field's niche capability.
• Arthrex: Arthrex is a privately held, surgeon-driven global medical device company with a strong hand, wrist, and upper-extremity portfolio including plating systems, compression screws, and intramedullary fixation. It is one of the most aggressive innovators in the extremities space and a key competitor for surgeon relationships and procedural adoption.

Direct peers

• Medartis AG: Medartis AG is Field Orthopaedics' exclusive global distribution partner for NX Nail and Micro Screw, and a direct competitor in the broader hand and extremity fixation market with its APTUS hand plate and screw portfolio. Both companies target hand and upper-extremity surgeons with titanium implants; Medartis is publicly listed on the Swiss Stock Exchange (MED.SW) and operates in 50+ countries.
• Acumed: Acumed is a privately held US orthopaedic device company with a deep specialty focus on hand, wrist, elbow, and shoulder fracture fixation — directly comparable to Field Orthopaedics' hand-only strategy. Both companies serve hand and upper-extremity surgeons with plates, screws, and intramedullary devices; Acumed is owned by Colson Medical.

Regional players

• Anika Therapeutics: Anika Therapeutics (US-listed) operates in regenerative and orthopaedic pain management, including hyaluronic acid-based treatments for hand and thumb arthritis (such as Hyalofast and viscosupplements). It is relevant as a thumb CMC OA competitor in the non-surgical/early-stage patient pathway where Field's Griplasty targets advanced-stage disease, making them partially adjacent rather than fully overlapping.

Emerging players

• Conventus Orthopaedics: Conventus Orthopaedics develops innovative extremity-specific implants (notably for distal radius and proximal humerus) using a proprietary cage-like technology. It overlaps with Field's extremities fixation focus but is at an earlier commercial stage and is privately held.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/FieldOrthopaedics
• LinkedInlinkedin.com/company/field-orthopaedics
• Instagraminstagram.com/field_orthopaedics

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Field Orthopaedics